Cite
APA Citation
Gandhi, S., Opyrchal, M., Ford, C., Fitzpatrick, V., Grimm, M., Basse, P., Quinn, M., Witkiewicz, A., Attwood, K., Ernstoff, M., O'Connor, T., Early, A., Levine, E., & Kalinski, P. (n.d.). 321 Phase I clinical trial assessing the combination of systemic chemokine modulatory regimen targeting TLR3 with neoadjuvant chemotherapy in triple negative breast cancer. Journal for immunotherapy of cancer, 8, A347. http://access.bl.uk/ark:/81055/vdc_100144712771.0x000002